syrup Articles
Four drugmakers to pay $124 million for submission of false claims to USA’s Medicaid
20 October 2009
Chugai/Roche to up Tamiflu supplies to Japan threefold
8 September 2009
Japan stock market week to May 25, 2009
27 May 2009
Four Novartis drugs and B-MS
9 March 2009
Lethal paracetamol hits Nigerian market
26 January 2009
Ono's interim results hit by NHI price cuts
8 December 2008
Call for AIDS "syrups" from MSF
1 September 2008
Japan stock market week to Aug 11, 2008
18 August 2008
217 drugs moved to OTC status in France
7 July 2008
Pediatric drug patent denied in India
30 June 2008
Taro gains final FDA appro for cetirizine
30 June 2008
Japan stock market week to May 26, 2008
2 June 2008
CHMP advises labeling change for S-P
17 March 2008
Panama govt issues fake drug death tally
25 February 2008
Japan stock market week to Jan 28, 2008
4 February 2008
US FDA approves new formulations of Zyrtec
26 November 2007
US study dismisses soft drink obesity link
3 September 2007
Japan stock market week to August 13, 2007
20 August 2007
US govt requests "rapid" drug action from China
6 August 2007
SFDA: "unsatisfactory" drug regulation in China
23 July 2007
Japan stock market week to May 28, 2007
4 June 2007
Chinese fake drug firm "not licensed"
14 May 2007
Ranbaxy gets tentative approval for cetirizine syrup
13 November 2006
34 killed in Panama by contaminated drugs
13 November 2006
Japan stock market week to July 17, 2006
24 July 2006
UCB sells Delsym to Adams RT for $122M
5 June 2006
Child-friendly HIV/AIDS drugs call to industry
5 December 2005
Schering-Plough aims for 100B yen sales in Japan by 2010
18 April 2005
South Africa awards ARV drug tenders
14 March 2005
Japan stock market week to February 21
28 February 2005
Fujisawa makes strategic drug transfers ahead of merger
28 February 2005
Taro Pharma gains FDA OK for generic loratadine syrup
30 August 2004
Tokyo pharma stocks - week to August 9
16 August 2004
CHPA says cough/cold drugs are safe and effective
19 July 2004
New chewable Zyrtec cleared by FDA
29 March 2004
WHO steps up action against substandard and counterfeit medicines
24 November 2003
Stock Commentary - Tokyo
2 June 2003
Taro Pharma 2nd qtr sales up 336%
29 July 2002
Ranbaxy set to launch Versed generic in USA
25 March 2002
CPMP backs new forms of S-P's desloratadine
14 January 2002
Unither to buy Coutances plant from Sanofi-Synthelabo
7 January 2002
Host of new products revealed in Ono Pharma's R&D pipeline
8 October 2001
Consumer groups sue S-P over Claritin claims
15 August 2001
Taro files ANDA to challenge S-P's Claritin
6 August 2001
S-P files for new desloratadine formulations
14 December 2000
Aventis seeks buyer for stake in R-P India
28 November 2000
Latest approvals from Japan's advisory board
25 October 2000
Indian malaria, asthma/ allergy price moves
10 October 2000
India's NPPA slashes 36 formulation prices
16 June 2000
Dutch OTC industry calls for self-selection
10 December 1999
Sincere Pharma set up in China's Jiangsu
7 December 1999
State of development in Ono Pharma R&D pipeline
10 November 1999
India revises the prices of 16 drug products
30 September 1999
Film/TV placement for cough/cold OTCs
23 September 1999
JB Chemicals selling ayurvedic cough syrup
28 July 1999
Parke Davis India reports profit fall
5 July 1999
Schering-Plough sues Copley over Claritin
29 March 1999
Japan's Ono Pharma Highlights R&D Pipeline
28 October 1998
Pediatric Versed Approved In USA
22 October 1998
Levalbuterol Nears Approval In USA
7 July 1998
Asta Comes Through Tough Year, Looks To Expansion
4 March 1998
Australia Excludes SSRIs From Final TGP Scheme
17 December 1997
GW's Zantac Knocked Off Top US Rx Drug Spot
4 September 1997
Clinton Plans New Rules On Child Drug Safety
19 August 1997
New CPAC Approvals Include Two NCEs
7 April 1997
Orphan Drug Designations In Japan
7 April 1997
Rhone-Poulenc Reorganizes In India
7 April 1997
Generic Ditropan From Morton
19 March 1997
WHO Warns On False Medicines "Ravaging World Markets"
11 November 1996
S-P's Claritin Syrup Approved In USA
28 October 1996
African Fake Vaccines Debacle Hits Merieux, SB
2 September 1996
Go-Ahead For Generic Albuterol In USA
8 January 1996
MSD Launch
24 April 1995
French drug Market "Will Decline 2%-4% This Year"
23 January 1995
Child-Resistant Containers In The UK
15 August 1994
Panel Backs Indication Extension For Retrovir
8 August 1994
CANADA OTC COUGH/ COLD SALES BOOM
21 March 1994
UCB INTRODUCES DRINKABLE FORMUALTION OF ZIRTEK
21 February 1994
POSSIBLE INFLUENZA TREATMENT
24 January 1994
LILLY REBUKED OVER FIALURIDINE DEATHS
20 December 1993
AL LABS RECEIVES APPROVAL
6 December 1993
103% NET INCOME RISE FOR ISRAEL's TEVA
22 November 1993
NIGERIAN COMPANIES SHOW GOOD PROGRESS
1 November 1993
NIKKEN LAUNCH
25 October 1993
SANDOZ SETTLES CHARGES
12 July 1993
KASEI DEAL WITH TANABE
26 April 1993
UNLICENSING drugs AND OFF-LABEL PRESCRIBING
14 December 1992
TEVA TO SIGN ACQUISITION DEAL
7 September 1992
CHANGES IN ISRAELI DRUG COSTS TO CONSUMERS
11 May 1992
TEVA'S GENERIC BRONCHODILATOR
20 April 1992
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Pfizer to split-off remaining 80% interest in Zoetis
